BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19758534)

  • 1. Selective serotonin reuptake inhibitor-induced spermatorrhea in 2 patients.
    Nakajima S; Uchida H; Suzuki T; Watanabe K; Kashima H
    J Clin Psychiatry; 2009 Aug; 70(8):1192-3. PubMed ID: 19758534
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual and auditory hallucinations associated with citalopram treatment.
    Waltereit R; Eifler S; Schirmbeck F; Zink M
    J Clin Psychopharmacol; 2013 Aug; 33(4):583-4. PubMed ID: 23775056
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regarding happiness pills].
    Starklint JF
    Ugeskr Laeger; 2013 Jun; 175(24):1744. PubMed ID: 23905178
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
    Aggarwal A; Jain M; Garg A; Jiloha RC
    Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
    [No Abstract]   [Full Text] [Related]  

  • 6. A selective serotonin reuptake inhibitor ameliorates obsessive-compulsive disorder-like perseverative behavior by attenuating 5-HT
    Hatakama H; Asaoka N; Nagayasu K; Shirakawa H; Kaneko S
    Neuropharmacology; 2022 Mar; 206():108926. PubMed ID: 34921828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
    Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
    J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid worsening of depressive symptoms in a patient with depression after switching from a TCA to an SSRI.
    Sato K; Yoshida K; Higuchi H; Shimizu T
    J Neuropsychiatry Clin Neurosci; 2002; 14(3):357. PubMed ID: 12154166
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors in children and adolescents.
    Diler RS; Avci A
    Swiss Med Wkly; 2002 Aug; 132(33-34):470-7. PubMed ID: 12458447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-response by age at onset in obsessive-compulsive disorder.
    Fontenelle LF; do Rosário-Campos MC; Mendlowicz MV; Ferrão YA; Versiani M; Miguel EC
    J Affect Disord; 2004 Dec; 83(2-3):283-4. PubMed ID: 15555726
    [No Abstract]   [Full Text] [Related]  

  • 13. Clomipramine discontinuation-emergent dystonia.
    Duggal HS; Dutta S; Sinha VK
    Aust N Z J Psychiatry; 2001 Oct; 35(5):696. PubMed ID: 11551294
    [No Abstract]   [Full Text] [Related]  

  • 14. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay.
    Safarinejad MR
    J Urol; 2008 Nov; 180(5):2124-8. PubMed ID: 18804223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S; Quercioli L; Bruscoli M
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive disorder in elderly patients.
    Jackson CW
    Drugs Aging; 1995 Dec; 7(6):438-48. PubMed ID: 8601051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
    Hammerness PG; Vivas FM; Geller DA
    J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of antidepressants.
    Artigas F; Nutt DJ; Shelton R
    Psychopharmacol Bull; 2002; 36 Suppl 2():123-32. PubMed ID: 12490828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline- and mirtazapine-induced severe neutropenia.
    Ozcanli T; Unsalver B; Ozdemir S; Ozmen M
    Am J Psychiatry; 2005 Jul; 162(7):1386. PubMed ID: 15994730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.